← Back to Search

Other

diet and lifestyle program for Obesity

Phase 1 & 2
Waitlist Available
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial is testing a diet intervention that is very low in carbohydrates.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in percent bodyweight
Secondary outcome measures
Change in HbA1c

Side effects data

From 2022 Phase 1 & 2 trial • 11 Patients • NCT05010070
9%
diarrhea
9%
flare up of dermatitis
9%
broken foot
100%
80%
60%
40%
20%
0%
Study treatment Arm
Diet and Lifestyle Program

Trial Design

1Treatment groups
Experimental Treatment
Group I: diet and lifestyle programExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
diet and lifestyle program
2017
Completed Phase 2
~170

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,797 Previous Clinical Trials
6,378,041 Total Patients Enrolled
33 Trials studying Obesity
9,948 Patients Enrolled for Obesity
Nutrition Science InitiativeOTHER
5 Previous Clinical Trials
985 Total Patients Enrolled
4 Trials studying Obesity
945 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of Michigan
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
~5 spots leftby Apr 2025